BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33449675)

  • 1. Therapeutic Vaccines for Cancer Immunotherapy.
    Wang J; Mamuti M; Wang H
    ACS Biomater Sci Eng; 2020 Nov; 6(11):6036-6052. PubMed ID: 33449675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
    Schijns V; Tartour E; Michalek J; Stathopoulos A; DobrovolskienÄ— NT; Strioga MM
    Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Cancer Vaccine Research.
    Liu N; Xiao X; Zhang Z; Mao C; Wan M; Shen J
    ACS Biomater Sci Eng; 2023 Nov; 9(11):5999-6023. PubMed ID: 37921277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of adjuvants for immunotherapy.
    Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges for cancer vaccine adjuvant development.
    Bowen WS; Svrivastava AK; Batra L; Barsoumian H; Shirwan H
    Expert Rev Vaccines; 2018 Mar; 17(3):207-215. PubMed ID: 29372660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
    Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
    Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Strategies to Boost Cancer Vaccines.
    Li WH; Li YM
    Chem Rev; 2020 Oct; 120(20):11420-11478. PubMed ID: 32914967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach.
    Kim CG; Sang YB; Lee JH; Chon HJ
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.
    Cuzzubbo S; Mangsbo S; Nagarajan D; Habra K; Pockley AG; McArdle SEB
    Front Immunol; 2020; 11():615240. PubMed ID: 33679703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. At the bench: Engineering the next generation of cancer vaccines.
    Shae D; Baljon JJ; Wehbe M; Becker KW; Sheehy TL; Wilson JT
    J Leukoc Biol; 2020 Oct; 108(4):1435-1453. PubMed ID: 31430398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma.
    Zhuang X; Wu T; Zhao Y; Hu X; Bao Y; Guo Y; Song Q; Li G; Tan S; Zhang Z
    J Control Release; 2016 Apr; 228():26-37. PubMed ID: 26921522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized cancer vaccines: adjuvants are important, too.
    Gouttefangeas C; Rammensee HG
    Cancer Immunol Immunother; 2018 Dec; 67(12):1911-1918. PubMed ID: 29644387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
    Moschella F; Proietti E; Capone I; Belardelli F
    Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-like nanomedicine for cancer immunotherapy.
    Yi Y; Yu M; Li W; Zhu D; Mei L; Ou M
    J Control Release; 2023 Mar; 355():760-778. PubMed ID: 36822241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response.
    Wang QT; Liu YX; Wang J; Wang H
    ChemMedChem; 2023 Jul; 18(13):e202200673. PubMed ID: 37088719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy.
    Lei L; Huang D; Gao H; He B; Cao J; Peppas NA
    Sci Adv; 2022 Nov; 8(47):eadc8738. PubMed ID: 36427310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injecting Hope--A Review of Breast Cancer Vaccines.
    Mittendorf EA; Peoples GE
    Oncology (Williston Park); 2016 May; 30(5):475-81, 485. PubMed ID: 27188680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.